Device
TIES® Transcutaneous Implant Evacuation System
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(50%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 1 finished
Non-Completion Rate
100.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
2
all time
Status Distribution
Active(1)
Terminated(1)
Detailed Status
Not yet recruiting1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
0
Success Rate
0.0%
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
not_yet_recruiting150%
terminated150%
Recent Activity
0 active trials
Showing 2 of 2
not_yet_recruitingnot_applicable
A Single-centre Open, Prospective, Pilot Clinical Study to Assess the Safety and Performance of the TIES® Transcutaneous Implant System in Patients Requiring a Permanent Ileostomy or Colostomy
NCT07413822
terminatednot_applicable
Safety, Performance and Durability of the TIES® Implant in Patients Requiring a Permanent Ileostomy
NCT03416023
Clinical Trials (2)
Showing 2 of 2 trials
NCT07413822Not Applicable
A Single-centre Open, Prospective, Pilot Clinical Study to Assess the Safety and Performance of the TIES® Transcutaneous Implant System in Patients Requiring a Permanent Ileostomy or Colostomy
NCT03416023Not Applicable
Safety, Performance and Durability of the TIES® Implant in Patients Requiring a Permanent Ileostomy
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2